Research article
Acute dosing of latrepirdine (Dimebon™), a possible Alzheimer therapeutic, elevates extracellular amyloid-β levels in vitro and in vivo
-
* Corresponding authors: David M Holtzman holtzman@neuro.wustl.edu - Sam Gandy samuel.gandy@mssm.edu
- † Equal contributors
Molecular Neurodegeneration 2009, 4:51 doi:10.1186/1750-1326-4-51
No comments have yet been made on this article.